[Lipid therapy with etofibrate. Reduction of multiple risk factors with an active substance. Report of an international seminar. 8-11 November 1989, Houston, Texas].
D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; C009746:etofibrate; D002995:Clofibric Acid; D002994:Clofibrate
Lipidtherapie mit Etofibrat. Reduktion multipler Risiken mit einem Wirkstoff. vom 8. bis 11. November 1989 in Houston/Texas.